Dailypharm Live Search Close

Daewoong Pharmaceutical's biggest quarterly performance ever

By Kim, Jin-Gu | translator Choi HeeYoung

22.08.01 06:00:05

°¡³ª´Ù¶ó 0
Second quarter operating profit of 33.6 billion

Nabota exports to the U.S. doubled in a year


Daewoong Pharmaceutical achieved its highest quarterly performance ever. Separately, sales in the second quarter increased 7.6% year-on-year to 293.8 billion won and operating profit increased 25.8% to 33.6 billion won. Both sales and operating profit are all-time highs based on quarterly performance. Earlier, Daewoong Pharmaceutical also set the highest quarterly operating profit in the first quarter. It then broke its quarterly operating profit record once again for the first time in a quarter.
 ¡ãNabota enters the European market in the second half of the year


Daewoong Pharmaceutical cited Nabota's propaganda as one of the reasons for achieving its biggest performance. According to the company, Nabota's second-quarter sales amounted to 37.1 billion won, up 60% fro

Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)